FindTrial
Sign In

The usage of amikacin sulfate in neonates

The usage of amikacin sulfate in 104 neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034644
Enrollment
Unknown
Registered
2020-07-12
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal septicemia

Interventions

Case series:none

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age of admission / or the corrected gestational age of 0-28 days. 2. usage of amikacin during hospitalization.

Exclusion criteria

Exclusion criteria: 1. has severe congenital malformation; 2. non-intravenous use; 3. the medical records are incomplete.

Design outcomes

Primary

MeasureTime frame
Renal function;Hearing;—

Countries

China

Contacts

Public ContactZhengli Wang

Children's Hospital of Chongqing Medical University

dengcgcb@163.com+86 18580183566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026